Immunology
-
Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In silico analysis
This article has 10 authors:Reviewed by ScreenIT
-
Early data on the performance of a combined SARS-CoV-2 spike-nucleocapsid antibody lateral flow device compared to a nucleocapsid-only device
This article has 3 authors:Reviewed by ScreenIT
-
SARS-CoV-2 reactive T cells in uninfected individuals are likely expanded by beta-coronaviruses
This article has 5 authors:Reviewed by ScreenIT
-
A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies
This article has 17 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
This article has 6 authors:Reviewed by ScreenIT
-
Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response
This article has 14 authors:Reviewed by ScreenIT
-
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
This article has 38 authors:Reviewed by ScreenIT
-
Systemic analysis of putative SARS-CoV-2 entry and processing genes in cardiovascular tissues identifies a positive correlation of BSG with age in endothelial cells
This article has 6 authors:Reviewed by ScreenIT
-
Distinct antibody repertoires against endemic human coronaviruses in children and adults
This article has 25 authors:Reviewed by ScreenIT
-
Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations
This article has 7 authors:Reviewed by ScreenIT